TickerFacts.

Xeris Biopharma Holdings, Inc. (XERS): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.08M
Year ended 2021-12-31
2020-12-31: $377.0K2021-12-31: $1.08M$1.08M
2020-12-31 Capital Expenditures (USD) 2021-12-31
Period endedCapital ExpendituresChange YoYSource filing
2021-12-31$1.08M+187.8%2022-03-11, From 2021-01-01
2020-12-31$377.0Kn/a2022-03-11, From 2020-01-01